Cargando…

STAG2 Protein Expression in Non–muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes

BACKGROUND: Mutations in STAG2 cause complete loss of STAG2 protein in approximately one-third of non–muscle-invasive bladder cancers (NMIBCs). STAG2 protein expression is easily determined via immunohistochemistry (IHC) and published data suggest that loss of STAG2 expression is a good prognostic i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Naheema S., Humayun-Zakaria, Nada, Goel, Anshita, Abbotts, Ben, Zeegers, Maurice P., Cheng, K.K., James, Nicholas D., Arnold, Roland, Bryan, Richard T., Ward, Douglas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Urothelial Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051973/ https://www.ncbi.nlm.nih.gov/pubmed/35495284 http://dx.doi.org/10.1016/j.euros.2022.02.004

Ejemplares similares

Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC Patients
por: Goel, Anshita, et al.
Publicado: (2020)

Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility
por: Mason, Jeremy, et al.
Publicado: (2021)

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer
por: Lindskrog, Sia V., et al.
Publicado: (2023)

Intraoperative Mitomycin C Bladder Instillation During Radical Nephroureterectomy Is Feasible and Safe
por: Nadler, Naomi, et al.
Publicado: (2021)

Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
por: Dobé, Tom-Régis, et al.
Publicado: (2020)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
por: Marcq, Gautier, et al.
Publicado: (2022)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
por: Humayun-Zakaria, Nada, et al.
Publicado: (2019)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
por: Paciotti, Marco, et al.
Publicado: (2021)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
por: Zschäbitz, Stefanie, et al.
Publicado: (2023)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020)

The Association Between Renal Function Decline and the Incidence of Urothelial Carcinoma: A 16-year Retrospective Cohort Study in Taiwan
por: Chuang, Yung-Hsin, et al.
Publicado: (2021)

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Khalid, Sidra, et al.
Publicado: (2020)

Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma
por: Hendriks, Nora, et al.
Publicado: (2022)

Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery
por: Soria, Francesco, et al.
Publicado: (2022)

Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
por: Miyake, Makito, et al.
Publicado: (2022)

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
por: Beijert, Irene J., et al.
Publicado: (2023)

Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison
por: Galtung, Kristina F., et al.
Publicado: (2023)

Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study
por: Bobjer, Johannes, et al.
Publicado: (2023)

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies
por: Mertens, Laura S., et al.
Publicado: (2023)

Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes
por: Goel, Anshita, et al.
Publicado: (2022)

Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumours
por: Llewellyn, Matthew A., et al.
Publicado: (2018)

PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
por: Dowell, Alexander C., et al.
Publicado: (2021)

Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes
por: Catto, James W.F., et al.
Publicado: (2021)

Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Ma, Runzhuo, et al.
Publicado: (2022)

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
por: Humayun-Zakaria, Nada, et al.
Publicado: (2021)

MRE11A Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation
por: Walker, Alexandra K., et al.
Publicado: (2019)

Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification
por: Snell, Kym I.E., et al.
Publicado: (2018)

Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts
por: van der Lelij, Petra, et al.
Publicado: (2017)

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation
por: Russo, Ilaria J., et al.
Publicado: (2018)

Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer
por: Ambrose, Sarah R., et al.
Publicado: (2015)

Perioperative immunotherapy in muscle-invasive bladder cancer
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Variant histology in bladder cancer: diagnostic and clinical implications
por: Black, Anna J., et al.
Publicado: (2020)

Review of non-invasive urinary biomarkers in bladder cancer
por: Lee, Hyung-Ho, et al.
Publicado: (2020)

Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2020)

Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer
por: Ward, Douglas G., et al.
Publicado: (2016)

Frequent truncating mutations of STAG2 in bladder cancer
por: Solomon, David A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cvk7dbb0jpkautl0dukrouog03